Global Antibody Drug Conjugates Market Size & Outlook

The antibody drug conjugates industry worldwide is expected to reach a projected revenue of US$ 21,508.1 million by 2030. A compound annual growth rate of 15.6% is expected of the worldwide antibody drug conjugates industry from 2022 to 2030.
Revenue, 2021 (US$M)
$5,811.8
Forecast, 2030 (US$M)
$22,870.9
CAGR, 2022 - 2030
16.4%
Report Coverage
Worldwide

Global antibody drug conjugates market highlights

  • The global antibody drug conjugates market generated a revenue of USD 5,811.8 million in 2021 and is expected to reach USD 22,870.9 million by 2030.
  • The market is expected to grow at a CAGR (2022 - 2030) of 16.4% by 2030.
  • In terms of segment, breast cancer accounted for a revenue of USD 3,166.5 million in 2021.
  • Other Cancer is the most lucrative application segment registering the fastest growth during the forecast period.
  • In terms of region, North America was the largest revenue generating market in 2021.
  • Country-wise, U.S. is expected to register the highest CAGR from 2022 to 2030.


Global data book summary

Market revenue in 2021USD 5,811.8 million
Market revenue in 2030USD 22,870.9 million
Growth rate16.4% (CAGR from 2021 to 2030)
Largest segmentBreast cancer
Fastest growing segmentOther Cancer
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBlood Cancer, Breast Cancer, Urothelial Cancer & Bladder Cancer, Other Cancer


Other key industry trends

  • In terms of revenue, the North America accounted for 56.6% of the global antibody drug conjugates market in 2021.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, U.S. is the fastest growing regional market and is projected to reach USD 10,163.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Antibody Drug Conjugates Market Companies

Name Profile # Employees HQ Website

Global antibody drug conjugates market size, by regions, 2018-2030 (US$M)

Top 10 countries: Antibody drug conjugates market size, 2021 (US$M)

Global antibody drug conjugates market share, by application, 2021 & 2030 (%, US$M)

Antibody drug conjugates market: Opportunity assessment by country

Global antibody drug conjugates market, by region, 2021 (US$M)

Global antibody drug conjugates market size, by regions, 2018-2030 (US$M)

Application 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 CAGR
North America 931.9 1,564.7 2,532.4 3,289.5 4,408.2 5,938.6 7,187.4 8,367.2 9,187.3 9,834.2 10,224.7 10,462.6 10,565.1 13.8%
Europe 627.4 729.7 997.0 1,299.4 1,977.2 2,682.2 3,379.8 4,038.8 4,612.8 5,128.3 5,570.4 6,003.4 6,385.4 19.4%
Asia Pacific 369.2 520.2 702.3 1,049.6 1,454.9 2,082.9 2,629.9 3,141.7 3,585.5 3,988.3 4,334.8 4,642.0 4,907.3 18.7%
Latin America 54.2 68.0 86.6 107.2 152.6 226.7 303.7 363.1 418.7 471.5 525.9 575.9 617.0 21.5%
MEA 41.5 47.8 54.4 66.1 93.2 139.2 183.3 221.3 259.9 295.4 333.3 367.3 396.2 22.0%
Overall 2,024.2 2,930.4 4,372.7 5,811.8 8,086.1 11,069.7 13,684.1 16,131.9 18,064.2 19,717.7 20,989.0 22,051.2 22,870.9 16.4%

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more